Improving Informed Decision Making for Cancer Clinical Trial Participation
NCT ID: NCT03820687
Last Updated: 2025-03-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
581 participants
INTERVENTIONAL
2023-02-08
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Health Literacy Intervention for Informed Consent of Cancer Patients Considering Clinical Trial Participation
NCT01964222
Personal Web Page In Clinical Trial Participant Education
NCT03887091
Clinical Trials Outreach & Education
NCT05064423
Intervention to Educate and Improve Underrepresented Populations' Participation in Clinical Trials
NCT04863092
Understanding Challenges, Behavioral Patterns, and Preferences Toward Participation in Clinical Trials in Minority Patient Populations: Development of a Personalized Clinical Trial Educational Platform to Increase Participation in Clinical Trials Among Underserved Cancer Patients
NCT04630431
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The community setting will involve a community awareness campaign including 400 community members, with 3 components: 1) an educational session delivered via PowerPoint presentation or flip chart, 2) a low-literacy booklet, and 3) support from a community health educator to raise awareness, positive attitudes and intentions to consider CTs as an appropriate treatment option for cancer and promote the MCC services among community members in Bexar County.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention Group
Participants in the intervention group will receive 3 components: 1) a bilingual, culturally tailored clinical trial educational video, 2) a low literacy booklet, and 3) support from a patient navigator to empower cancer patients to make informed decisions about cancer clinical trial participation by increasing awareness of clinical trials and MCC services, positive attitudes and intentions to consider clinical trials as an appropriate treatment option for cancer.
Clinical Trial Educational Video
Bilingual, culturally tailored educational video, low literacy booklet, and support from a patient navigator to empower new cancer patients to make informed decisions about cancer clinical trial participation.
Low literacy booklet
A bilingual low-literacy booklet with educational content about clinical trials.
Navigator
Support will be provided by a patient navigator to empower cancer patients to make an informed decision about cancer clinical trial participation by increasing awareness of clinical trials and MCC services, positive attitudes, and intentions to consider clinical trials as an appropriate treatment option for cancer.
Usual Care Control Group
Participants in the usual care control group will receive a general clinical trial fact sheet.
Clinical Trial Fact Sheet
General Clinical Trial fact sheet with usual care information regarding Clinical Trials.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Clinical Trial Educational Video
Bilingual, culturally tailored educational video, low literacy booklet, and support from a patient navigator to empower new cancer patients to make informed decisions about cancer clinical trial participation.
Clinical Trial Fact Sheet
General Clinical Trial fact sheet with usual care information regarding Clinical Trials.
Low literacy booklet
A bilingual low-literacy booklet with educational content about clinical trials.
Navigator
Support will be provided by a patient navigator to empower cancer patients to make an informed decision about cancer clinical trial participation by increasing awareness of clinical trials and MCC services, positive attitudes, and intentions to consider clinical trials as an appropriate treatment option for cancer.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who have not participated in a Clinical Trial before
* English or Spanish-speaking
* Able to provide informed consent
Exclusion Criteria
* Patients who have already had a consultation with their doctor to discuss treatment options
* Patients who have participated in a Clinical Trial before
* Unable to provide informed consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Genentech, Inc.
INDUSTRY
The University of Texas Health Science Center at San Antonio
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Patricia Chalela
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amelie G Ramirez, DrPH, MPH
Role: PRINCIPAL_INVESTIGATOR
UT Health San Antonio
Patricia Chalela, DrPH, MPH
Role: PRINCIPAL_INVESTIGATOR
UT Health San Antonio
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Texas Health Science Center San Antonio, MCC
San Antonio, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HSC20180283H
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.